Baxter Hlthcare Corp Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?
BAXTER HLTHCARE CORP has fifty-seven approved drugs.
There are thirteen US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.
There are six patent family members on BAXTER HLTHCARE CORP drugs in five countries and one hundred and seven supplementary protection certificates in fourteen countries.
Summary for Baxter Hlthcare Corp
International Patents: | 6 |
US Patents: | 13 |
Tradenames: | 68 |
Ingredients: | 44 |
NDAs: | 57 |
Drugs and US Patents for Baxter Hlthcare Corp
Expired US Patents for Baxter Hlthcare Corp
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | 4,262,003 | See Plans and Pricing |
Baxter Hlthcare Corp | CLINOLIPID 20% | olive oil; soybean oil | EMULSION;INTRAVENOUS | 204508-001 | Oct 3, 2013 | 5,840,757 | See Plans and Pricing |
Baxter Hlthcare Corp | DOXIL (LIPOSOMAL) | doxorubicin hydrochloride | INJECTABLE, LIPOSOMAL;INJECTION | 050718-002 | Jun 13, 2000 | 5,213,804 | See Plans and Pricing |
Baxter Hlthcare Corp | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018799-001 | Dec 13, 1982 | 3,629,425 | See Plans and Pricing |
Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | 4,031,894 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Baxter Hlthcare Corp Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112022015170 | See Plans and Pricing |
Australia | 2021233893 | See Plans and Pricing |
Canada | 3170514 | See Plans and Pricing |
China | 115243675 | See Plans and Pricing |
Canada | 3070798 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0984957 | 300483 | Netherlands | See Plans and Pricing | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
1534313 | C 2015 055 | Romania | See Plans and Pricing | PRODUCT NAME: COMBINATIE DE FENILEFRINA SAU O SARE ACCEPTABILAFARMACEUTIC A ACESTEIA SI KETOROLAC SATIONAL AUTHORISATION: 20150728; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/15/1018; DATE OF FIRST AUTHORISATION IN EEA: 20150728 U O SARE ACCEPTABILA FARMACEUTIC AACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/15/1018; DATE OF NA |
2957286 | C02957286/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66411 22.12.2017 |
2957286 | SPC/GB19/003 | United Kingdom | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721 |
1499331 | 13C0055 | France | See Plans and Pricing | PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.